Evolve Global Healthcare Enhanced Yield Fund (TSX: LIFE)
Assets | 223.78M |
Expense Ratio | 0.74% |
PE Ratio | 30.58 |
Dividend (ttm) | 1.95 |
Dividend Yield | 8.76% |
Ex-Dividend Date | Jul 31, 2024 |
Payout Frequency | Monthly |
Payout Ratio | n/a |
1-Year Return | +6.43% |
Volume | 4,633 |
Open | 21.55 |
Previous Close | 21.56 |
Day's Range | 21.49 - 21.58 |
52-Week Low | 19.32 |
52-Week High | 22.88 |
Beta | 0.64 |
Holdings | 101 |
Inception Date | Oct 25, 2017 |
About LIFE
Evolve Global Healthcare Enhanced Yield Fund is an exchange traded fund launched and managed by Evolve Funds Group Inc. The fund invests in public equity markets of global region. It invests directly and through derivatives in stocks of companies operating across health care sectors. The fund uses derivatives such as options to create its portfolio. It invests in growth and value stocks of large-cap companies. The fund seeks to track the performance of the Solactive Global Healthcare 20 Index Canadian Dollar Hedged. Evolve Global Healthcare Enhanced Yield Fund was formed on October 24, 2017 and is domiciled in Canada.
Performance
LIFE had a total return of 16.96% in the past year. Since the fund's inception, the average annual return has been 9.29%, including dividends.
Top 10 Holdings
125.88% of assetsName | Symbol | Weight |
---|---|---|
Canadian Dollar | n/a | 77.49% |
AbbVie Inc. | ABBV | 5.58% |
Thermo Fisher Scientific Inc. | TMO | 5.46% |
Danaher Corporation | DHR | 5.45% |
Roche Holding AG | RHHBY | 5.43% |
Sanofi | SNY | 5.41% |
Intuitive Surgical, Inc. | ISRG | 5.36% |
Abbott Laboratories | ABT | 5.28% |
Johnson & Johnson | JNJ | 5.22% |
Boston Scientific Corporation | BSX | 5.20% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Sep 27, 2024 | 0.190 CAD | Oct 4, 2024 |
Aug 30, 2024 | 0.190 CAD | Sep 9, 2024 |
Jul 31, 2024 | 0.190 CAD | Aug 8, 2024 |
Jun 28, 2024 | 0.160 CAD | Jul 8, 2024 |
May 31, 2024 | 0.160 CAD | Jun 7, 2024 |
Apr 29, 2024 | 0.160 CAD | May 7, 2024 |